Pediatrix Medical Group (NYSE:MD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Pediatrix Medical Group (MD) Delivers Higher Q3 Earnings Despite Sales Dip—Is Profitability Now the Focus? [Yahoo! Finance]
Pediatrix Medical Group (NYSE:MD) had its price target raised by analysts at Truist Financial Corporation from $17.00 to $24.00. They now have a "hold" rating on the stock.
5 Must-Read Analyst Questions From Pediatrix Medical Group's Q3 Earnings Call [Yahoo! Finance]